Taking Wegovy Every 10 Days: What the Prescribing Schedule Actually Allows

The misconception: that a slightly longer gap is a safe way to ease side effects

One of the most common reasons people search this question is nausea. The first few weeks on Wegovy can feel rough for some people, and the idea of spreading injections out a little (10 days instead of seven) sounds like a reasonable compromise. It isn't, and it's worth being direct about why.

Semaglutide works by maintaining a steady level of the medicine in your system. Its half-life is roughly seven days, which is precisely why once-weekly dosing was chosen. At a 10-day interval, the circulating level of semaglutide drops more substantially before your next injection, and the renewed rise after each dose can actually make gastrointestinal symptoms worse rather than better. You'd be trading a consistent therapeutic effect for a cycle of relative peaks and troughs, the opposite of what the schedule is designed to achieve.

If nausea or other GI symptoms are the driver here, the right conversation is with your prescriber. Slowing the titration (staying on a lower dose for longer before moving up) is a legitimate, supported option. That's a clinical adjustment made with evidence; stretching the interval on your own is not.

What actually happens if one dose lands late

Life is unpredictable. A dose gets forgotten, a delivery is delayed, or the week runs away from you, these things happen. The NHS semaglutide guidance addresses this practically: if you remember a missed dose and there are still at least five days until your next scheduled injection, take it. If fewer than five days remain, skip the missed dose entirely and continue with your normal weekly day.

That five-day rule means a dose taken two or three days late is not catastrophic. What it does not mean is that injecting every 10 days is an acceptable ongoing rhythm. Occasional lateness and deliberate interval-stretching are different things. One is a recovered slip; the other is an unapproved departure from the licensed schedule that undermines the treatment.

People sometimes wonder whether a similar question applies to semaglutide in other contexts, there's a related discussion on semaglutide dosing intervals that covers the broader picture.

Could taking it less often work for weight loss at all?

It's a fair question, and it deserves a straight answer. The clinical trials that established Wegovy's effectiveness (and led to its UK licence) were all conducted on a strict once-weekly protocol. STEP 1, the pivotal 68-week trial published in the New England Journal of Medicine, produced an average weight reduction of around 15% on that schedule. There is no equivalent trial evidence for a 10-day interval. Extrapolating from pharmacokinetics alone, you would expect reduced efficacy: less medicine in your system near the end of each extended interval, less appetite suppression, potentially more variability in how you feel week to week.

If cost is part of the calculation (fewer pens per month at a longer interval) it's worth reading about what Wegovy costs in the UK and what a private prescription genuinely includes, because the maths on self-adjusted dosing rarely works out in the patient's favour once effectiveness is factored in. The better route to affordability is transparency about what's included, not quietly reducing your dose frequency.

For anyone wondering about the outer edges of interval variation, there are also dedicated pages on taking Wegovy every two weeks and, at the other end, whether a shorter five-day interval might be appropriate, though neither replaces clinical guidance.

What your prescriber should know if you're struggling with the schedule

If you're finding the weekly injection difficult (whether that's side effects, needle anxiety, or simply forgetting) tell your prescriber. That's not a conversation to avoid. A prescriber can look at where you are in the titration, review whether the current dose is appropriate, and consider whether the newer oral option might suit you better. These are clinical decisions made with your full picture in view.

At nume, a real clinician reads every consultation (not a triage algorithm) and aftercare is available seven days a week precisely for moments like this. If you're already on Wegovy and hitting a rough patch, reaching out to our team is the sensible first step before adjusting anything yourself. Worth noting: questions about gallstones, which can be relevant for people on GLP-1 medicines, are covered separately for anyone who needs that guidance, see our page on Wegovy and gallstones.

If you're earlier in your journey and still working out whether Wegovy is the right treatment for you, our Wegovy overview covers eligibility, the titration schedule, and what to expect, and BMI requirements for Wegovy sets out the licensed thresholds clearly. When you're ready to speak to our prescribers, you can start a free consultation here.